Amsterdam’s NLC Health Ventures raises €14M to back healthcare innovations

|

|

Last update:

Amsterdam-based NLC Health Ventures, a healthtech venture builder, has secured €14M in funding from private investors and family offices. 

In addition to private investors, NLC has also garnered support from governmental and public sector entities, including Bpifrance, the French public sector bank, and the NHS, the UK’s publicly funded healthcare system.

The company is in the advanced due diligence phase with the expectation of revealing its first two institutional investors in April of this year.

According to Impact Investor, with this round, NLC has raised a total of €58M since the beginning of 2023 and €180M since its establishment in 2015.

Capital utilisation

The funding, secured through a mix of debt and convertible notes, will help NLC fuel its international expansion, boost venture creation, and support the existing portfolio of nearly 90 ventures, reports Impact Investor.

Once fully invested, NLC Health Impact Fund would invest in between 80 and 90 ventures. The fund has made 17 investments, including the latest in Nicolab, an AI-based decision support platform for stroke diagnosis. Other investments include Scinvivo and PEP Health.

- A message from our partner -

Launchpad for healthcare innovations

NLC operates in the venture-building sector, supporting the introduction of healthcare innovations to the market. The company directly backs its investees or channels support through its four funds. 

With a focus on biotech, medtech, green health, and digital health, NLC has invested in over 100 innovations to date.

NLC aims to enhance health and make it accessible to all. “By using entrepreneurship at scale, our unique NLC approach allows us to find inventions, and create and support ventures that have the potential to reach the patient,” says the firm.

NLC Health Ventures mentions in a LinkedIn post, “At NLC, our investments prioritise innovations that significantly improve existing technologies, positively impact patients and society, and have commercial viability.”

“But building a healthtech venture differs significantly from your typical startup. And that’s where NLC stands out. We understand the challenges in an industry as complex as healthcare and provide comprehensive support that goes beyond the monetary aspect.”

“Our approach includes strategic guidance and operational resources, creating a supportive ecosystem for ventures to thrive. We offer strategic guidance and operational resources, creating a supportive ecosystem that goes beyond the monetary aspect.”

Topics:

Follow us:

Vishal Singh

Vishal Singh is a News Reporter and Social Media Marketing Lead at Silicon Canals. He covers developments in the European startup ecosystem and oversees the publication's social media presence. Before joining Silicon Canals, Vishal gained experience at the Indian digital media outlet Inc42, contributing to its growth with insightful content. Despite being a college dropout, his passion for writing has driven his career in journalism.

Amsterdam’s NLC Health Ventures raises €14M to back healthcare innovations

|

|

Last update:

Amsterdam-based NLC Health Ventures, a healthtech venture builder, has secured €14M in funding from private investors and family offices. 

In addition to private investors, NLC has also garnered support from governmental and public sector entities, including Bpifrance, the French public sector bank, and the NHS, the UK’s publicly funded healthcare system.

The company is in the advanced due diligence phase with the expectation of revealing its first two institutional investors in April of this year.

According to Impact Investor, with this round, NLC has raised a total of €58M since the beginning of 2023 and €180M since its establishment in 2015.

Capital utilisation

The funding, secured through a mix of debt and convertible notes, will help NLC fuel its international expansion, boost venture creation, and support the existing portfolio of nearly 90 ventures, reports Impact Investor.

Once fully invested, NLC Health Impact Fund would invest in between 80 and 90 ventures. The fund has made 17 investments, including the latest in Nicolab, an AI-based decision support platform for stroke diagnosis. Other investments include Scinvivo and PEP Health.

- A message from our partner -

Launchpad for healthcare innovations

NLC operates in the venture-building sector, supporting the introduction of healthcare innovations to the market. The company directly backs its investees or channels support through its four funds. 

With a focus on biotech, medtech, green health, and digital health, NLC has invested in over 100 innovations to date.

NLC aims to enhance health and make it accessible to all. “By using entrepreneurship at scale, our unique NLC approach allows us to find inventions, and create and support ventures that have the potential to reach the patient,” says the firm.

NLC Health Ventures mentions in a LinkedIn post, “At NLC, our investments prioritise innovations that significantly improve existing technologies, positively impact patients and society, and have commercial viability.”

“But building a healthtech venture differs significantly from your typical startup. And that’s where NLC stands out. We understand the challenges in an industry as complex as healthcare and provide comprehensive support that goes beyond the monetary aspect.”

“Our approach includes strategic guidance and operational resources, creating a supportive ecosystem for ventures to thrive. We offer strategic guidance and operational resources, creating a supportive ecosystem that goes beyond the monetary aspect.”

Topics:

Follow us:

Share to...